The product is indicated for the treatment of adults with mild, moderate and severe infections.
Levofloxacin oral solution 25mg/ml is the generic version of McNeil Pharmaceutical’s Levaquin oral solution, is used to treat mild, moderate and severe infections in adults.
Hi-Tech Pharmacal expects to receive final approval from the FDA in June 2011 when the brand’s pediatric exclusivity expires related to patent number 5,053,407.
Hi-Tech intends to introduce of levofloxacin oral solution 25mg/ml in June 2011 upon receipt of final approval.